|Articles|March 1, 2020

BioPharm International

  • BioPharm International-03-01-2020
  • Volume 33
  • Issue 3

BioPharm International, March 2020 Issue (PDF)

Click the title above to open the BioPharm International March 2020 issue in an interactive PDF format.
To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

almost 6 years ago

Improving Upstream Predictability

almost 6 years ago

The Future of Raw Material Sources for mAbs

almost 6 years ago

Building Data Quality in Generates Quality Data Out

almost 6 years ago

Flexible Facilities for Viral Vector Manufacturing

almost 6 years ago

Stability Testing: The Crucial Development Step

almost 6 years ago

Navigating GMPs for Gene Therapies

almost 6 years ago

The Costs of Commercializing CRISPR

almost 6 years ago

Seeking Early Answers to Formulation Questions

almost 6 years ago

Drug Production Draws Multiple Contenders

almost 6 years ago

Coronavirus Response: Reaction or New Reality?

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!